HWG Holdings LP Buys New Stake in Brainsway Ltd. Sponsored ADR $BWAY

Key Points

• HWG Holdings LP acquired 253,050 shares of Brainsway in the third quarter, valued at approximately $3.34 million and representing a 0.63% stake. Hedge funds and institutional investors collectively own 30.11% of the company.
• Analysts maintain a generally positive outlook, with five Buy ratings and two Holds. Brainsway has a “Moderate Buy” consensus rating and an average price target of $18.20, above its reported share price of $11.62.
• Brainsway exceeded quarterly expectations, reporting $0.14 in EPS versus the $0.10 consensus estimate and revenue of $17.11 million versus $16.54 million expected. The stock has traded between $7.14 and $17.40 over the past year.

HWG Holdings LP purchased a new stake in Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 253,050 shares of the company's stock, valued at approximately $3,340,000. HWG Holdings LP owned 0.63% of Brainsway at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in BWAY. Masters Capital Management LLC increased its holdings in shares of Brainsway by 65.0% in the first quarter. Masters Capital Management LLC now owns 1,650,000 shares of the company's stock worth $21,928,000 after purchasing an additional 650,000 shares during the period. Renaissance Technologies LLC increased its stake in Brainsway by 87.2% in the 1st quarter. Renaissance Technologies LLC now owns 518,420 shares of the company's stock worth $6,890,000 after acquiring an additional 241,560 shares during the last quarter. Y.D. More Investments Ltd increased its stake in Brainsway by 136.6% in the 1st quarter. Y.D. More Investments Ltd now owns 272,004 shares of the company's stock worth $3,615,000 after acquiring an additional 157,042 shares during the last quarter. Sei Investments Co. raised its holdings in shares of Brainsway by 262.5% in the 1st quarter. Sei Investments Co. now owns 226,378 shares of the company's stock valued at $3,009,000 after acquiring an additional 163,925 shares in the last quarter. Finally, Tidal Investments LLC raised its holdings in shares of Brainsway by 492.8% in the 2nd quarter. Tidal Investments LLC now owns 89,248 shares of the company's stock valued at $1,384,000 after acquiring an additional 74,193 shares in the last quarter. 30.11% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have recently commented on BWAY shares. Wall Street Zen raised Brainsway from a "hold" rating to a "buy" rating in a report on Sunday, August 2nd. HC Wainwright reaffirmed a "buy" rating and issued a $19.00 target price on shares of Brainsway in a research note on Tuesday, September 8th. BTIG Research reissued a "buy" rating and issued a $20.00 price target on shares of Brainsway in a research note on Thursday, September 10th. New Street Research restated a "buy" rating on shares of Brainsway in a research report on Friday, July 24th. Finally, Weiss Ratings downgraded shares of Brainsway from a "buy (b-)" rating to a "hold (c+)" rating in a report on Wednesday, August 19th. Five research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $18.20.

Brainsway Price Performance

NASDAQ:BWAY opened at $11.62 on Thursday. The business has a 50 day moving average of $14.25 and a 200 day moving average of $14.73. The company has a market capitalization of $467.59 million, a price-to-earnings ratio of 26.41 and a beta of 1.29. Brainsway Ltd. Sponsored ADR has a 1-year low of $7.14 and a 1-year high of $17.40.

Brainsway (NASDAQ:BWAY - Get Free Report) last issued its quarterly earnings results on Wednesday, August 12th. The company reported $0.14 EPS for the quarter, beating analysts' consensus estimates of $0.10 by $0.04. The business had revenue of $17.11 million for the quarter, compared to analysts' expectations of $16.54 million. Brainsway had a net margin of 15.65% and a return on equity of 12.74%. As a group, sell-side analysts anticipate that Brainsway Ltd. Sponsored ADR will post 0.33 EPS for the current year.

Brainsway Company Profile

BrainsWay Ltd. is a medical technology company that develops and commercializes noninvasive treatments for brain disorders. Its primary technology, Deep Transcranial Magnetic Stimulation (Deep TMS), uses electromagnetic fields to stimulate targeted areas of the brain and is delivered through specialized treatment systems and helmet-like coils.

The company's Deep TMS platform is used by healthcare providers in the treatment of major depressive disorder, obsessive-compulsive disorder and smoking addiction, subject to applicable regulatory clearances and local treatment guidelines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.